djr-1.1

Caenorhabditis elegans

Predicted to enable glyoxalase III activity. Involved in several processes, including cellular aldehyde metabolic process; cellular response to aldehyde; and monocarboxylic acid biosynthetic process. Located in cytoplasm and nucleus. Expressed in intestine. Used to study Parkinson's disease. Human ortholog(s) of this gene implicated in Parkinson's disease 7; Parkinsonism; and middle cerebral artery infarction. Is an ortholog of human PARK7 (Parkinsonism associated deglycase).

djr-1.2

Caenorhabditis elegans

Predicted to enable glyoxalase III activity. Involved in cellular aldehyde metabolic process; cellular response to aldehyde; and monocarboxylic acid biosynthetic process. Located in cytoplasm. Expressed in several structures, including excretory canal; inner labial neurons; phasmid neurons; rectal gland cell; and ventral nerve cord. Used to study Parkinson's disease. Human ortholog(s) of this gene implicated in Parkinson's disease 7; Parkinsonism; and middle cerebral artery infarction. Is an ortholog of human PARK7 (Parkinsonism associated deglycase).

C15F1.14

Caenorhabditis elegans

Is affected by cep-1; adr-1; and sftb-1 based on RNA-seq studies.

C17G10.14

Caenorhabditis elegans

Is affected by adr-1; etr-1; and ogt-1 based on RNA-seq studies.

C41C4.18

Caenorhabditis elegans

Is affected by prg-1; hsf-1; and glp-1 based on RNA-seq studies.

F18C5.15

Caenorhabditis elegans

Is affected by cep-1; dlc-1; and ogt-1 based on RNA-seq studies.

F26D11.15

Caenorhabditis elegans

Is affected by cep-1; dlc-1; and glp-1 based on RNA-seq studies.

R05F9.14

Caenorhabditis elegans

Is affected by adr-1; etr-1; and ogt-1 based on RNA-seq studies.

T23F2.9

Caenorhabditis elegans

Is affected by etr-1; hpk-1; and ogt-1 based on RNA-seq studies.

Y38E10A.33

Caenorhabditis elegans

Is affected by adr-1; olrn-1; and ogt-1 based on RNA-seq studies.